Katzav S[au] - Search Results

Year	Number of Results
1976	1
1980	2
1981	3
1982	3
1983	4
1984	1
1985	3
1986	2
1989	2
1990	1
1991	2
1992	3
1993	2
1994	2
1995	4
1996	1
1998	1
1999	1
2000	3
2002	2
2003	4
2004	2
2006	1
2007	3
2008	1
2009	2
2010	2
2011	2
2012	1
2013	2
2014	1
2015	3
2018	3
2019	2
2020	2
2022	0

1

Vav1 mutations: What makes them oncogenic?

Farago M, Yarnitzky T, Shalom B, Katzav S. Farago M, et al. Among authors: katzav s. Cell Signal. 2020 Jan;65:109438. doi: 10.1016/j.cellsig.2019.109438. Epub 2019 Oct 22. Cell Signal. 2020. PMID: 31654719 Free article. Review.

2

Mutations of c-Cbl in myeloid malignancies.

Katzav S, Schmitz ML. Katzav S, et al. Oncotarget. 2015 May 10;6(13):10689-96. doi: 10.18632/oncotarget.3986. Oncotarget. 2015. PMID: 26028666 Free PMC article. Review.

3

vav: a molecule for all haemopoiesis?

Katzav S. Katzav S. Br J Haematol. 1992 Jun;81(2):141-4. doi: 10.1111/j.1365-2141.1992.tb08198.x. Br J Haematol. 1992. PMID: 1386524 Review. No abstract available.

4

Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.

Katzav S. Katzav S. Oncotarget. 2015 Oct 6;6(30):28731-42. doi: 10.18632/oncotarget.5086. Oncotarget. 2015. PMID: 26353933 Free PMC article. Review.

5

Vav1: a hematopoietic signal transduction molecule involved in human malignancies.

Katzav S. Katzav S. Int J Biochem Cell Biol. 2009 Jun;41(6):1245-8. doi: 10.1016/j.biocel.2008.11.006. Epub 2008 Nov 30. Int J Biochem Cell Biol. 2009. PMID: 19100858 Review.

6

Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy?

Lazer G, Katzav S. Lazer G, et al. Among authors: katzav s. Cell Signal. 2011 Jun;23(6):969-79. doi: 10.1016/j.cellsig.2010.10.022. Epub 2010 Oct 30. Cell Signal. 2011. PMID: 21044680 Review.

7

Vav proteins, masters of the world of cytoskeleton organization.

Hornstein I, Alcover A, Katzav S. Hornstein I, et al. Among authors: katzav s. Cell Signal. 2004 Jan;16(1):1-11. doi: 10.1016/s0898-6568(03)00110-4. Cell Signal. 2004. PMID: 14607270 Review.

8

Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Katzav S, Cleveland JL, Heslop HE, Pulido D. Katzav S, et al. Mol Cell Biol. 1991 Apr;11(4):1912-20. doi: 10.1128/mcb.11.4.1912-1920.1991. Mol Cell Biol. 1991. PMID: 2005887 Free PMC article.

9

Vav1: an oncogene that regulates specific transcriptional activation of T cells.

Katzav S. Katzav S. Blood. 2004 Apr 1;103(7):2443-51. doi: 10.1182/blood-2003-08-2834. Epub 2003 Oct 30. Blood. 2004. PMID: 14592821 Free article. Review.

10

Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.

Katzav S. Katzav S. Cancer Lett. 2007 Oct 8;255(2):241-54. doi: 10.1016/j.canlet.2007.04.015. Epub 2007 Jun 21. Cancer Lett. 2007. PMID: 17590270 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results